Striking a balance between exacerbation prevention and pneumonia risk

Sponsored by A. Menarini Pty Ltd.

The link between the use of inhaled corticosteroids (ICS) and pneumonia in people with COPD remains unclear, with conflicting data and no clear biological mechanisms, a respiratory insights forum held in Melbourne has been told. Speaking during a session called ‘ICS and pneumonia risk’ Professor Ian Yang, Director of Thoracic Medicine at The Prince Charles ...

Already a member?

Login to keep reading.

© 2021 the limbic